Highlights of the 2017 European <scp>AIDS</scp> Clinical Society (EACS) Guidelines for the treatment of adult <scp>HIV</scp>‐positive persons version 9.0Lene Ryom, Manuel Battegay, Christoph Boesecke et al.|HIV Medicine|2018Cited by 138
Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohortJosep M. Llibre, JM Miró, Peré Domingo et al.|HIV Medicine|2019Cited by 38